23 марта, 22:25

Keysight (KEYS): Solid Stock for a Winning Portfolio

Keysight (KEYS) has consistently impressed shareholders over the last year. Let's delve a deeper look on its growth prospects, know what's propelling the stock and why should you buy it.

Выбор редакции
23 марта, 19:00

U.S. Is Not Saudi Arabia’s Only Option For Nuclear Power

The United States is not Saudi Arabia’s only option when it comes to developing nuclear energy projects, Energy Minister Khalid al-Falih said during Crown Prince Mohammed’s two-week visit in the U.S. Reuters quoted the official as saying that if the United States declined to help the Kingdom develop its nuclear power industry, it would lose an opportunity to “influence the programme in a positive way.” This, however, would not stop the Saudis from tapping uranium enrichment and plutonium reprocessing technology: besides…

23 марта, 17:52

Universal Technical's Transformation Plan to Boost Growth

The Strategic Transformation Plan is likely to boost enrollment, which will drive revenues for Universal Technical (UTI).

23 марта, 16:24

Zacks.com featured highlights include: Caterpillar, athenahealth, Antero, Pioneer and Concho

Zacks.com featured highlights include: Caterpillar, athenahealth, Antero, Pioneer and Concho

Выбор редакции
23 марта, 16:00

Sabor, London W1 | Grace Dent’s restaurant review

A new Spanish restaurant that continues the fine tradition begun by the same team that set up BarrafinaSabor has taken root on Heddon Street, W1. If you know London only as a tourist, however briefly, you’ll have been within a whisker of this spot where chef Nieves Barragán Mohacho and front-of-house José Etura’s new place now sits. Heddon Street is a back passage, a well-trampled crevice, off Regent Street, so it’s quite literally tourist central.“We have walked the length and breadth of London,” my northern relatives will claim after an exhausting day out, and it will turn out later that they meandered all of 900 metres from Oxford Street to Piccadilly Circus. Sabor sits between those two points. A word to the wise: it’s within emergency vermouth-on-tap supping distance of the Build-a-Bear Workshop at Hamleys, with Yzaguirre Blanco at £5 a glass and prawn croquetas that are tiny portions of heaven. But whether or not passing trade, chancing on the place, will love it as London’s food scene already loves it is open to question. For Sabor comes wrapped in a backstory, while Barragán has been adored and respected for years by the capital’s chefs, diners and even nippy critics such as myself. The coming of Sabor is a big deal. Continue reading...

23 марта, 15:40

Why Keysight (KEYS) Stock is a Must-Add to Your Portfolio

Keysight (KEYS) has consistently impressed shareholders over the last year. Let's delve a deeper look on its growth prospects, know what's propelling the stock and why should you buy it.

Выбор редакции
23 марта, 14:00

Seven Valuable Resources Boston Business Owners Can Tap Into

Developing your business takes long hours and a lot of work. Here are some resources you can use to help your organization grow.

23 марта, 02:50

Trump replaces McMaster, taps Bolton as national security adviser

WASHINGTON (Reuters) - U.S. President Donald Trump shook up his foreign policy team again on Thursday, replacing H.R. McMaster as national security adviser with John Bolton, a hawk who has advocated using military force against North Korea and Iran.

23 марта, 02:19

Trump ousts McMaster, taps Bolton as national security adviser

WASHINGTON (Reuters) - U.S. President Donald Trump on Thursday chose as his new national security adviser John Bolton, a hawk who has advocated using military force against Iran and North Korea and has taken a hard line against Russia.

Выбор редакции
23 марта, 02:09

Boost Social Security Checks By Tapping IRAs Early Suggests Study

Social Security monthly payments can be boosted by using early Auto-IRA withdrawals says a new report

22 марта, 19:01

Midea taps demand for robotics

Midea Group plans to increase industrial robot production capacity by fourfolds to 100,000 units annually by 2024, the Shenzhen-listed firm said yesterday.

Выбор редакции
22 марта, 18:55

Tap creative industries to boost Africa’s economic growth

The continent has long been ripe with talent and cultural riches

22 марта, 16:55

Dive Into These ETFs & Stocks on World Water Day

We have highlighted some water ETFs and stocks that could be excellent picks to tap the growing opportunity.

22 марта, 16:12

5 Top Stocks to Tap Earnings Beat Potential

These top-ranked stocks are likely to beat on bottom line in their next releases.

Выбор редакции
Выбор редакции
22 марта, 12:21

Dutch say 'no' in referendum on spy agency tapping powers

AMSTERDAM (Reuters) - Dutch voters have narrowly rejected a law that would give spy agencies the power to carry out mass tapping of Internet traffic delivering a setback to Prime Minister Mark Rutte's government.

Выбор редакции
22 марта, 11:16

Dutch referendum: Spy tapping powers vote too close to call

The "no" vote is marginally ahead with most results counted, as new spying powers split the country.

22 марта, 05:10

Not The Fed's Fault: Kolanovic Blames Stock Sell Off On "Severe Snowstorm"

When it comes to the Fed's quarterly (and soon monthly) press conferences, it's widely expected that the Fed chair will manipulate and goalseek the message to reach a desired market outcome. After all, if the past ten years have taught us something, it is that the Fed only cares about the market reaction and micromanaging equities. And to do that, the chair will do and say anything, obfuscating - in the best Alan Greenspan tradition, putting the audience to sleep - as only Janet Yellen can, and generally lying as much as needed to give traders the comfort that the Fed is "with them." The problem is when research analysts start doing the same, and instead of at least pretending to be intellectually honest, they steamroll through the facts and create a fabricated version of reality, padded by hubris, meant to validated their version of the world, no matter how wrong. We are sad to note that JPM's head quant Marko Kolanovic has done just that tonight, and in a note meant to validate his recent uber-bullish outlook, 'explains' that the stock reaction to the Fed is not what it should have been - even if that's not the case for other asset classes, which slumped admirably, i.e. just as Kolanovic had expected, and suggest a "near-term goldilocks environment. As for equities, here Kolanovic finds offence because the "price action of the S&P 500 was not coherent", i.e., they also went down: "first we saw a strong rally and reversal, then another (smaller) rally and reversal, with the market ending slightly down." But if bonds and FX were right and stocks were wrong, and the Fed was dovish, something has to explain this divergence in reactions, right? Yup, and according to Kolanovic - the most respected quant at JPMorgan - the answer is.... snow. We are not joking: the man who for the past 3 years has been explaining how the market is almost entirely controlled by algos, latent positioning, and generally non-human reactions, stakes his reputation - to use a Gartman term - that it was the lack of carbon-based traders, that spoiled the market response Kolanovic had been hoping for. Here is his note. Bond yields went lower, USD weakened, and the yield curve steepened – all of which are positive (dovish) signals for US equities As we suggested in our previous note (here), fears of the Fed delivering a hawkish message did not materialize. 2018 dots were not revised higher, and the importance of the 2019/2020 dots was downplayed by Powell (realistically, no one can have visibility 2 years out). Bond yields went lower, USD weakened, and the yield curve steepened – all of which are positive (dovish) signals for US equities. Furthermore, there was no significant change in inflation expectations and the growth outlook, alleviating recent equity markets concerns. This outcome is a positive and indicates that equity investors could expect a near term goldilocks environment. In contrast to the Fed, price action of the S&P 500 was not coherent - first we saw a strong rally and reversal, then another (smaller) rally and reversal, with the market ending slightly down. We note that this happened on very low volumes (particularly in light of the importance and anticipation of the catalyst). This was likely the result of a severe snowstorm affecting the US northeast and incomplete market participation (e.g. it was one of the lowest futures contract volumes on any Fed announcement days). Market direction was further confused by the initial reaction of bonds and rotation out of tech and momentum stocks, inflows into small cap, value and high volatility stocks, and covering of high short interest stocks. Well, yeah, it's always something else when the market doesn't do as you had expected. And while by now it is all too clear that Marko got one or more taps on the shoulder to toe the JPM bullish line no questions asked, here it is once again. We maintain our positive near term view on US equities. Our view is that the path of recovery is likely to mimic the August 2015 selloff that was also driven by systematic selling (Figure below compares equity price action in the aftermath of August 2015 and February 2018), as market volatility subsides (prompting re-leveraging of systematic  strategies), continuation of strong buyback demand, and focus shifting to strong upcoming earnings season. At least Kolanovic did not again warn that Trump faces impeachment if he dares to launch a trade war with China (which he will do tomorrow at 12:30pm), and risk sending the precious S&P lower. And now, those who are eager to bet on whose reputation is torn apart first: that of Gartman, who last week made a "watershed call"  that the market has hit all time highs, or Kolanovic, who recently predicted that the market will keep rising to new records, you can make your bets now.

Выбор редакции
22 марта, 02:03

Exit polls: Dutch vote on spying law too close to call

A left-wing environmentalist party scored strongly in key Dutch municipal elections Wednesday, exit polls suggest, while a referendum on a law granting intelligence agencies far-reaching powers to tap electronics communications was too close to call.

22 марта, 01:29

Trump administration taps AIDS researcher to lead CDC

The Trump administration will appoint prominent HIV/AIDS researcher Robert Redfield to lead the CDC, administration officials announced Wednesday amid new scrutiny of controversies surrounding his earlier research and views.Redfield, a clinical scientist and former Army doctor who co-founded the Institute of Human Virology at the University of Maryland School of Medicine, has been leading a massive HIV treatment program and a global program funded by the President’s Emergency Plan for AIDS Relief. He previously served on former President George W. Bush’s HIV/AIDS advisory panel and in various advisory roles at NIH.The appointment comes nearly two months after former CDC Director Brenda Fitzgerald resigned following a POLITICO investigation that revealed she had traded tobacco, drug and food stocks while leading the country’s top public health agency. Redfield emerged as the favorite to take the top CDC job last week, POLITICO reported over the weekend. Sources close to the decision process say Redfield was chosen based on his groundbreaking work on HIV/AIDS in Maryland. The position does not require Senate confirmation.“Dr. Redfield has dedicated his entire life to promoting public health and providing compassionate care to his patients, and we are proud to welcome him as director of the world’s premier epidemiological agency," HHS Secretary Alex Azar said in a statement.Redfield's expected appointment has revived examination of controversial positions he took decades ago. At a time when effective treatments for HIV/AIDS weren’t yet available, he expressed support for mandatory HIV testing and identifying by name patients who tested positive for the virus — practices that were staunchly opposed by patient advocates. Sen. Patty Murray (D-Wash.), the top Democrat on the HELP Committee, had asked President Donald Trump to reconsider his appointment, citing those views.Redfield’s colleagues defended his record, saying he was motivated by a desire to help his patients.“He took a position not caring about the politics,” said Robert Gallo, who co-founded the Institute of Human Virology and has worked closely with Redfield for decades. “That was a time of a lot of panic and a lot of pressure politically in a lot of directions. Bob, in his position in the Army, was concerned about soldiers and I’m sure he acted in the best interest of his patients.”Critics have also raised questions about his oversight of a failed effort to develop an AIDS vaccine at the Walter Reed Army Institute of Research in the early 1990s. A whistleblower who came forward this week said he believed Redfield was either sloppy with data or fabricated the results. The Army cleared him of wrongdoing but said there were accuracy issues with the data. Redfield has tried to address criticism in recent days by privately assuring public health and HIV/AIDS advocacy groups that he is committed to science-based approaches in all areas of CDC’s work, according to multiple sources familiar with those conversations.Some public health experts are cautiously optimistic about the new CDC director, pointing out that his controversial views were held decades ago and the science and public understanding of HIV/AIDS has changed dramatically since then.“Questions raised by his past views are legitimate and I would love to know what he currently thinks,” said Jeffrey Crowley, former director of the Office of National AIDS Policy under President Barack Obama. “But what we need to recognize is the epidemic today looks very different than it did then and technology has changed our views dramatically. Redfield is a respected scientist and we could do far worse by some other appointment.”Redfield has also participated in Maryland’s response to the opioid crisis, including the development of medication-assisted treatment facilities, according to colleagues. “He has been a leader on the opioid epidemic,” said Carlos del Rio, a professor of medicine at Emory University and chair of PEPFAR’s Scientific Advisory Board, which Redfield also serves on. “Right now, our biggest public health problem is the opioid crisis, and we need someone who actually understands and wants to do something about it.”Some public health experts respect his research background but question whether he has enough experience to lead a massive government agency like the Atlanta-based CDC, which has been under threat of budget cuts by Congress and the Trump administration. The president’s 2019 budget proposal called for a $900 million cut to the agency. “He’s a strong scientist and has really sound science credentials. The only red flag is that he hasn’t led an institution like this,” said Scott Becker, executive director of the Association of Public Health Laboratories. “The ability to really be a strong leader and spend time on Capitol Hill educating Congress about the importance of public health investments is really important.” Lawmakers made no secret they were frustrated that Redfield’s predecessor, Fitzgerald, often recused herself from key public health issues, such as the opioid crisis and cancer, on the account of her financial conflicts. Her resignation in late January came after just nearly seven months in the job.Redfield’s appointment has already been supported by some lawmakers, including Rep. Elijah Cummings, a Democrat from his home state of Maryland."Although I seldom agree with the Trump administration, I am in complete agreement that Dr. Bob Redfield is the best choice to lead the CDC," Cummings said in a statement. "Bob has devoted his life to improving the public health.”Longtime CDC official Anne Schuchat, who had been acting director since Fitzgerald's resignation, will return to her job as principal deputy director.Adam Cancryn contributed to this report.